Lorcaserin
CAMELLIA-TIMI
Novo Nordisk · Phase 4 · Completed · Enrollment 14673
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Lorcaserin hydrochloride (HCL)10 mg | Obesity + T2D | 10 mg | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Lorcaserin
Novo Nordisk · Phase 4 · Completed · Enrollment 14673
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Lorcaserin hydrochloride (HCL)10 mg | Obesity + T2D | 10 mg | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |